Literature DB >> 24154963

Alzheimer's disease biomarkers: walk with deliberate haste, don't run blithely on?

William T Hu1, Leslie M Shaw, John Q Trojanowski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24154963      PMCID： PMC3873221          DOI： 10.1007/s00401-013-1197-3

Source DB:  PubMed          Journal:  Acta Neuropathol        ISSN： 0001-6322            Impact factor:   17.088


× No keyword cloud information.
  12 in total

1.  The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Guy M McKhann; David S Knopman; Howard Chertkow; Bradley T Hyman; Clifford R Jack; Claudia H Kawas; William E Klunk; Walter J Koroshetz; Jennifer J Manly; Richard Mayeux; Richard C Mohs; John C Morris; Martin N Rossor; Philip Scheltens; Maria C Carrillo; Bill Thies; Sandra Weintraub; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

2.  Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Reisa A Sperling; Paul S Aisen; Laurel A Beckett; David A Bennett; Suzanne Craft; Anne M Fagan; Takeshi Iwatsubo; Clifford R Jack; Jeffrey Kaye; Thomas J Montine; Denise C Park; Eric M Reiman; Christopher C Rowe; Eric Siemers; Yaakov Stern; Kristine Yaffe; Maria C Carrillo; Bill Thies; Marcelle Morrison-Bogorad; Molly V Wagster; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

3.  The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease.

Authors:  Marilyn S Albert; Steven T DeKosky; Dennis Dickson; Bruno Dubois; Howard H Feldman; Nick C Fox; Anthony Gamst; David M Holtzman; William J Jagust; Ronald C Petersen; Peter J Snyder; Maria C Carrillo; Bill Thies; Creighton H Phelps
Journal:  Alzheimers Dement       Date:  2011-04-21       Impact factor: 21.566

Review 4.  Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid.

Authors:  Heiko Braak; Henrik Zetterberg; Kelly Del Tredici; Kaj Blennow
Journal:  Acta Neuropathol       Date:  2013-06-12       Impact factor: 17.088

Review 5.  Consensus report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease". The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group.

Authors: 
Journal:  Neurobiol Aging       Date:  1998 Mar-Apr       Impact factor: 4.673

6.  Use of florbetapir-PET for imaging beta-amyloid pathology.

Authors:  Christopher M Clark; Julie A Schneider; Barry J Bedell; Thomas G Beach; Warren B Bilker; Mark A Mintun; Michael J Pontecorvo; Franz Hefti; Alan P Carpenter; Matthew L Flitter; Michael J Krautkramer; Hank F Kung; R Edward Coleman; P Murali Doraiswamy; Adam S Fleisher; Marwan N Sabbagh; Carl H Sadowsky; Eric P Reiman; P Eric M Reiman; Simone P Zehntner; Daniel M Skovronsky
Journal:  JAMA       Date:  2011-01-19       Impact factor: 56.272

Review 7.  Cerebral amyloid PET imaging in Alzheimer's disease.

Authors:  Clifford R Jack; Jorge R Barrio; Vladimir Kepe
Journal:  Acta Neuropathol       Date:  2013-10-08       Impact factor: 17.088

8.  Longitudinal change in CSF Tau and Aβ biomarkers for up to 48 months in ADNI.

Authors:  Jon B Toledo; Sharon X Xie; John Q Trojanowski; Leslie M Shaw
Journal:  Acta Neuropathol       Date:  2013-06-29       Impact factor: 17.088

9.  CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer's disease.

Authors:  Jon B Toledo; Ane Korff; Leslie M Shaw; John Q Trojanowski; Jing Zhang
Journal:  Acta Neuropathol       Date:  2013-06-29       Impact factor: 17.088

10.  Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson disease.

Authors:  Jing Zhang; Hayley A Mattison; Changqin Liu; Carmen Ginghina; Peggy Auinger; Michael P McDermott; Tessandra Stewart; Un Jung Kang; Kevin C Cain; Min Shi
Journal:  Acta Neuropathol       Date:  2013-05-04       Impact factor: 17.088
View more
  2 in total

1.  A platelet protein biochip rapidly detects an Alzheimer's disease-specific phenotype.

Authors:  Michael Veitinger; Rudolf Oehler; Ellen Umlauf; Roland Baumgartner; Georg Schmidt; Christopher Gerner; Rita Babeluk; Johannes Attems; Goran Mitulovic; Eduard Rappold; John Lamont; Maria Zellner
Journal:  Acta Neuropathol       Date:  2014-09-24       Impact factor: 17.088

2.  CSF complement 3 and factor H are staging biomarkers in Alzheimer's disease.

Authors:  William T Hu; Kelly D Watts; Prashant Tailor; Trung P Nguyen; Jennifer C Howell; Raven C Lee; Nicholas T Seyfried; Marla Gearing; Chadwick M Hales; Allan I Levey; James J Lah; Eva K Lee
Journal:  Acta Neuropathol Commun       Date:  2016-02-17       Impact factor: 7.801
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.